Design of and rationale for the Japan Diabetes Optimal Integrated Treatment study for 3 major risk factors of cardiovascular diseases (J-DOIT3): a multicenter, open-label, randomized, parallel-group trial
Kohjiro Ueki, Takayoshi Sasako, Masayuki Kato, Yukiko Okazaki, Sumie Okahata, Hisayuki Katsuyama, Mikiko Haraguchi, Ai Morita, Ken Ohashi, Kazuo Hara, Atsushi Morise, Kazuo Izumi, Yasuo Ohashi, Mitsuhiko Noda, Takashi Kadowaki, the J-DOIT3 Study Group
BMJ Open Diabetes Research and Care Jan 2016, 4 (1) e000123; DOI: 10.1136/bmjdrc-2015-000123
